EX-FILING FEES 4 ex_703274.htm EXHIBIT FILING FEES ex_703274.htm

 

Exhibit 107

 

 

 

Calculation of Filing Fee Table

FORM S-8

 

Registration Statement Under the Securities Act of 1933

(Form Type)

 

 

 

Ekso Bionics Holdings, Inc.

(Exact Name of the Registrant as Specified in its Charter)

 

 

Table 1: Newly
Registered Securities

Security

Type

Security Class Title

Fee

Calculation

Rule

Amount

Registered

Proposed

Maximum

Offering

Price Per

Unit

Maximum
aggregate

offering
price

Fee Rate

Amount of

registration

fee

Equity

Common stock, par value $0.001 per share:

457(c) and 457(h)

1,000,000 (2)

$1.2925 (3)

$1,292,500 (3)

0.00014760

$190.77 (3)

Total Offering Amounts

 

$1,292,500

 

$190.77

Total Fee Offsets

     

$0.00

Net Fee Due

     

$190.77

 

(1)

This Registration Statement covers shares of our common stock, $0.001 par value per share, of Ekso Bionics Holdings, Inc., or the Registrant, authorized for issuance pursuant to the Ekso Bionics Holdings, Inc. Amended and Restated 2014 Equity Incentive Plan (the “Restated Plan”).

(2)

This Registration Statement registers 1,000,000 shares of common stock for issuance pursuant to the Restated Plan. In accordance with Rule 416 under the Securities Act, this Registration Statement shall be deemed to cover an indeterminate number of additional shares of common stock, as may be issuable pursuant to future stock dividends, stock splits, or similar transactions.

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act, based on the average of the high ($1.355) and low ($1.23) prices of the Registrant's common stock as reporting on the Nasdaq Capital Market, which was $1.2925 on July 23, 2024.